Unknown Author
January 24, 2026
Kirkland Advises GTCR-Backed RevSpring on Sale to Frazier Healthcare

1 min
AI-made summary
- Kirkland & Ellis advised GTCR and its portfolio company RevSpring, Inc
- on the sale of RevSpring to Frazier Healthcare Partners, a healthcare-focused investment firm
- RevSpring provides communication and payment solutions for healthcare and financial services, handling 1.5 billion communications and over $8 billion in payment volume annually
- The transaction was announced on March 12, 2024, with a Kirkland team comprising corporate, debt finance, and tax partners and associates.
Kirkland & Ellis advised GTCR and its portfolio company RevSpring, Inc. on its sale to healthcare-focused investment firm Frazier Healthcare Partners. RevSpring is a leading provider of end-to-end communication and payment solutions in healthcare and financial services, sending 1.5 billion communications and processing more than $8 billion in payment volume annually for its healthcare and financial services customers. The transaction was announced March 12, 2024. Read RevSpring’s press release The Kirkland team was led by corporate partners Neil K. Vohra and Mark Fennell and included corporate associates Jessica Lowe, Paul Koltz, with support from corporate partner Sanford Perl and associates Brian Arnfelt and Francesco Castaldi; debt finance partners Tom Dobleman and Patrick Loughery and associate Alex Straka; and tax partners Polina Liberman and Michael Alcan.
Article Author
Unknown Author
The Sponsor
